Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Aprea Therapeutics Inc fell by 7.14m. Cash Flow from Financing totalled 5.14m or 881.30% of revenues. In addition the company used 12.18m for operations while cash used for investing totalled 93.09k.
Cash flow per share | -2.72 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.28 |
---|---|
Tangible book value per share | 4.28 |
More ▼
Balance sheet in USDView more
Current ratio | 7.28 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼